TXT In plain English
Company description
ORGANON PHARMA (UK) LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 25 September 1964; registered for 62 years; registered office reported in CRAMLINGTON, UNITED KINGDOM. Its primary declared activity is 21100 · Manufacture of basic pharmaceutical products.
This BritDB profile also contains linked public records: 3 PSC records, 14 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- ORGANON PHARMA (UK) LIMITED
- Company number
- 00820771
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 0 total · 0 outstanding · 0 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2025Next accounts due
30 September 2027Last statement made up to
10 July 2026Next statement due
24 July 2027BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- -9.7%
- Mean bonus gap
- -18.8%
- Women receiving bonus
- 88.7%
- Men receiving bonus
- 93.3%
- Women in top quartile
- 50.9%
- Women in upper middle quartile
- 33.0%
- Women in lower middle quartile
- 31.8%
- Women in lower quartile
- 43.2%
Earlier reporting years (7)
- 500 to 999-7.8% median hourly gap
- 500 to 999-12.5% median hourly gap
- 500 to 999-8.0% median hourly gap
- 500 to 999-5.3% median hourly gap
- 1000 to 4999-3.3% median hourly gap
- 1000 to 4999-5.8% median hourly gap
- 1000 to 4999-6.7% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 13 July 2026
- Shortest standard term
- 0 days
- Longest standard term
- 90 days
- E-invoicing offered
- Yes
- Supply-chain finance
- Not offered
- Payment codes
- No
- Construction retentions
- No qualifying construction contracts
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £5,823,296
- Invoice value paid in 31–60 days
- £23,309,905
- Invoice value paid after 60 days
- £23,914,059
- Invoice value paid outside agreed terms
- £19,159,199
- Invoices paid in 31–60 days
- 14.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 90 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Reported terms and dispute process
- Standard payment terms
90 days with two payment runs per month. Payment terms can be adjusted for SMEs
- Dispute resolution process
All enquires and complaints can be logged with our dedicated Helpdesk (telephone and email). Issues generallyrelate to incorrect invoice submissions including incorrect amounts, incorrect/missing PO information andincorrect/missing VAT numbers. The metrics of the Helpdesk are reviewed for quality/effectiveness on a monthlybasis. An independently staffed Speak Up Tool provides a forum for suppliers to raise ethical concernsanonymously, though it helps if as much information is provided to resolve the issue/complaint.
Earlier payment reports (11 shown)
- 66.0 average days to pay55.0% outside terms
- 87.0 average days to pay44.0% outside terms
- 96.0 average days to pay49.0% outside terms
- 88.0 average days to pay32.0% outside terms
- 104.0 average days to pay36.0% outside terms
- 50.0 average days to pay20.0% outside terms
- 61.0 average days to pay14.0% outside terms
- 57.0 average days to pay11.0% outside terms
- 63.0 average days to pay14.0% outside terms
- 80.0 average days to pay9.0% outside terms
- 79.0 average days to pay8.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Supply-chain transparency
Modern slavery statement
- Organisation
- ORGANON PHARMA (UK) LIMITED
- Group submission
- No
- Statement period
- 1 January 2025 – 31 December 2025
- Approved
- 11 May 2026
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- £100 million to £500 million
- Years producing statements
- More than 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 27 May 2026
Earlier linked statements (2)
- ORGANON PHARMA (UK) LIMITED31 December 2020
- ORGANON PHARMA (UK) LIMITED31 December 2020
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
06 Data protection
ICO fee-payer registration
Organon Pharma (UK) Limited
Registration Z5688899
- Registered from
- 24 September 2001
- Current end date
- 23 September 2027
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
07 Environmental regulation
Environment Agency records
ORGANON PHARMA (UK) LIMITED
EPR/ZP3524SD · NE23 3JU
- Permit or record holder
- ORGANON PHARMA (UK) LIMITED
- Record date
- 12 March 2024
- Local authority
- Northumberland
- Regulated site or public record address
- Organon Pharma (UK), Organon Pharma (UK), Shotton Lane, Northumberland, Cramlington, NE23 3JU
- Activity
- MCP
- Grid reference
- NZ2422878764
- Easting
- 424228.000
- Northing
- 578764.000
- All populated source fields
- Permission Number: EPR/ZP3524SD; Name: ORGANON PHARMA (UK) LIMITED; Activity Type Description: MCP; Site Address: Organon Pharma (UK), Organon Pharma (UK), Shotton Lane, Northumberland, Cramlington, NE23 3JU; Site Postcode: NE23 3JU; Site Grid Reference: NZ2422878764; Easting: 424228; Northing: 578764; Local Authority: Northumberland; Permission Date: 2024-03-12
These are candidate company associations. The public-register downloads do not supply Companies House numbers. BritDB requires one unique exact holder-name and postcode match; the regulated site may differ from the registered office, so verify the record at source.
08 Public procurement
Contracts Finder awards
Obstetrics, Gynaecology & Sexual Health
Supply Chain Coordination Limited · ocds-b5fd17-80d2c63e-a307-42b2-b2a4-5a9aedf067a4
- Supplier named in award
- Organon Pharma (UK) Limited
- Award value
- £61,600,000
- Contract period
- 1 July 2025 – 30 June 2027
- Published
- 17 June 2025
- Procedure
- Open procedure (above threshold)
- Main CPV
- 03116000
- Source release ID
- ocds-b5fd17-80d2c63e-a307-42b2-b2a4-5a9aedf067a4-2025-06-17T10:36:50+01:00
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England · ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9
- Supplier named in award
- Organon Pharmaceuticals
- Award value
- £1
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 13 May 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9-2021-05-13T10:21:38+01:00
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England · ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef
- Supplier named in award
- Organon Pharmaceuticals
- Award value
- £228,156,862
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 30 April 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef-2021-04-30T13:00:26+01:00
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
- Supplier named in award
- Merck Sharp & Dohme Ltd
- Award value
- £191,062,951
- Contract period
- 1 September 2020 – 31 August 2022
- Published
- 15 September 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67-2020-09-15T14:26:04+01:00
NHS Framework Agreement - North of England - Tranche B
NHS England · ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
- Supplier named in award
- MERCK SHARP & DOHME LIMITED
- Award value
- £205,535,556
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 25 March 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef-2020-03-25T08:39:13Z
NHS Midlands and East Branded Medicines - Tranche A
NHS England · ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8
- Supplier named in award
- MSD
- Award value
- £418,787,000
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 13 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8-2020-02-13T09:40:57Z
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
NHS England · ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349
- Supplier named in award
- MERCK SHARP & DOHME LIMITED
- Award value
- £188,004,961
- Contract period
- 1 September 2019 – 31 August 2021
- Published
- 17 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349-2019-10-17T10:16:17+01:00
Contract for the supply of Meales, Mumps and Rubella (MMR) vaccine
DEPARTMENT OF HEALTH · ocds-b5fd17-bd0faec4-adc9-11e6-9901-0019b9f3037b
- Supplier named in award
- Merck, Sharpe and Dohme
- Award value
- £0
- Contract period
- 1 April 2020 – 31 March 2022
- Published
- 7 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33651000
- Source release ID
- ocds-b5fd17-bd0faec4-adc9-11e6-9901-0019b9f3037b-2019-08-07T10:05:31+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- Merck Sharp & Dohme (MSD)
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
Contract for the supply of human papillomavirus vaccine
Department of Health and Social Care · ocds-b5fd17-ea718a21-658b-429f-b5b0-6272f650a0f3
- Supplier named in award
- Merck, Sharp and Dohme
- Award value
- £0
- Contract period
- 1 July 2019 – 30 June 2020
- Published
- 17 May 2019
- Procedure
- Negotiated procedure without prior publication (above threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-ea718a21-658b-429f-b5b0-6272f650a0f3-2019-05-17T11:21:28+01:00
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- MSD
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
NHS England Framework Agreement - London - Tranche A
NHS England · ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351
- Supplier named in award
- Merck Sharp & Dohme (MSD)
- Award value
- £211,435,404
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 7 November 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351-2018-11-07T09:28:44Z
NHS Framework Agreement for Trastuzumab Injection
NHS England · ocds-b5fd17-b6a072b1-6044-401b-8e44-c5d6a74b23ff
- Supplier named in award
- Merck Sharp & Dohme (MSD)
- Award value
- £226,961,206.42
- Contract period
- 16 July 2018 – 31 August 2019
- Published
- 11 September 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-b6a072b1-6044-401b-8e44-c5d6a74b23ff-2018-09-11T10:15:23+01:00
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
09 Ownership and control
People with significant control
Organon & Co.
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United States
- Legal authority
- State Of Delaware
- Legal form
- Corporation
- Place registered
- Delaware (Division Of Corporations)
- Registration number
- 7834229
- Notified
- 2 June 2021
Merck & Co., Inc.
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United States
- Legal authority
- State Of New Jersey
- Legal form
- Corporation
- Place registered
- Business Register - New Jersey Division Of Revenue
- Registration number
- 7954-6100-00
- Notified
- 22 March 2021
- Ceased
- 2 June 2021
Merck Sharp & Dohme (Uk) Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United Kingdom
- Legal authority
- United Kingdom
- Legal form
- Limited Company
- Place registered
- England And Wales
- Registration number
- 00233687
- Notified
- 6 April 2016
- Ceased
- 22 March 2021
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
10 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
11 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
12 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
13 Public procurement
Find a Tender links
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
14 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
15 Nature of business
Standard Industrial Classification
16 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
1 procurement process linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
17 Record timeline
Dates in the bulk record
- Detected change
Accounts due date: 2026-09-30 → 2027-09-30
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Company name
Previous name: MERCK SHARP & DOHME LIMITED
- Incorporation
Company incorporated
18 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Candidate permit and enforcement associations based on a unique exact holder-name and postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.